Show simple item record

dc.contributor.authorWasunna, M
dc.contributor.authorNjenga, S
dc.contributor.authorBalasegaram, M
dc.contributor.authorAlexander, N
dc.contributor.authorOmollo, R
dc.contributor.authorEdwards, T
dc.contributor.authorDorlo, TPC
dc.contributor.authorMusa, B
dc.contributor.authorAli, MHS
dc.contributor.authorElamin, MY
dc.contributor.authorKirigi, G
dc.contributor.authorJuma, R
dc.contributor.authorKip, AE
dc.contributor.authorSchoone, GJ
dc.contributor.authorHailu, A
dc.contributor.authorOlobo, J
dc.contributor.authorEllis, S
dc.contributor.authorKimutai, R
dc.contributor.authorWells, S
dc.contributor.authorKhalil, EAG
dc.contributor.authorStrub Wourgaft, N
dc.contributor.authorAlves, F
dc.contributor.authorMusa, A
dc.date.accessioned2016-10-10T18:56:41Z
dc.date.available2016-10-10T18:56:41Z
dc.date.issued2016-09-14
dc.date.submitted2016-09-21
dc.identifier.citationEfficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial. 2016, 10 (9):e0004880 PLoS Negl Trop Disen
dc.identifier.issn1935-2735
dc.identifier.pmid27627654
dc.identifier.doi10.1371/journal.pntd.0004880
dc.identifier.urihttp://hdl.handle.net/10144/618678
dc.description.abstractSSG&PM over 17 days is recommended as first line treatment for visceral leishmaniasis in eastern Africa, but is painful and requires hospitalization. Combination regimens including AmBisome and miltefosine are safe and effective in India, but there are no published data from trials of combination therapies including these drugs from Africa.
dc.language.isoenen
dc.publisherPublic Library of Science (PLoS)en
dc.rightsArchived with thanks to PLoS Neglected Tropical Diseasesen
dc.titleEfficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trialen
dc.identifier.journalPLoS Neglected Tropical Diseasesen
refterms.dateFOA2019-03-04T12:55:38Z
html.description.abstractSSG&PM over 17 days is recommended as first line treatment for visceral leishmaniasis in eastern Africa, but is painful and requires hospitalization. Combination regimens including AmBisome and miltefosine are safe and effective in India, but there are no published data from trials of combination therapies including these drugs from Africa.


Files in this item

Thumbnail
Name:
Wasunna M et al - 2016 - Efficacy ...
Size:
933.0Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record